secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001193125-26-140267
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics approves 1-for-25 reverse stock split to meet Nasdaq $1.00 minimum bid price
--------------------------------------------------------------------------------

- Reverse split at 1-for-25, effective 12:01 a.m. ET on April 2, 2026; shares drop from ~171.6M to ~6.86M.
- Action taken to increase per-share price above Nasdaq's $1.00 minimum bid requirement for continued listing.
- No fractional shares issued; cash in lieu; new CUSIP 72941H806; trading symbol stays PSTV.
- Broadridge acts as exchange agent; book-entry holders need no action; certificates receive instructions.
- Par value unchanged at $0.001; proportional adjustments to equity awards and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526140267/0001193125-26-140267-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526140267/pstv-20260401.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-140267

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer